Kovitz Investment Group Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-83,096
| Closed | -$8.33M | – | 1351 |
|
|
2025
Q3 | $8.33M | Buy |
83,096
+363
| +0.4% | +$32.7K | 0.03% | 360 |
|
|
2025
Q2 | $6.86M | Buy |
82,733
+11,570
| +16% | +$923K | 0.03% | 381 |
|
|
2025
Q1 | $5.77M | Buy |
71,163
+14,084
| +25% | +$1.26M | 0.03% | 382 |
|
|
2024
Q4 | $5.14M | Buy |
57,079
+201
| +0.4% | +$19.5K | 0.03% | 392 |
|
|
2024
Q3 | $5.56M | Buy |
56,878
+218
| +0.4% | +$21.4K | 0.04% | 327 |
|
|
2024
Q2 | $5.25M | Buy |
56,660
+3,954
| +8% | +$355K | 0.04% | 278 |
|
|
2024
Q1 | $5M | Buy |
52,706
+852
| +2% | +$79.1K | 0.06% | 203 |
|
|
2023
Q4 | $4.63M | Sell |
51,854
-17,153
| -25% | -$1.27M | 0.08% | 162 |
|
|
2023
Q3 | $5.04M | Buy |
69,007
+5,856
| +9% | +$468K | 0.09% | 136 |
|
|
2023
Q2 | $5.25M | Sell |
63,151
-4,335
| -6% | -$363K | 0.08% | 137 |
|
|
2023
Q1 | $5.14M | Sell |
67,486
-10,775
| -14% | -$894K | 0.09% | 146 |
|
|
2022
Q4 | $6.5M | Buy |
78,261
+14,179
| +22% | +$1.15M | 0.13% | 112 |
|
|
2022
Q3 | $5.08M | Buy |
64,082
+3,399
| +6% | +$287K | 0.12% | 140 |
|
|
2022
Q2 | $4.51M | Buy |
60,683
+1,388
| +2% | +$104K | 0.1% | 160 |
|
|
2022
Q1 | $5.33M | Buy |
59,295
+28,195
| +91% | +$2.6M | 0.1% | 151 |
|
|
2021
Q4 | $4.38M | Buy |
31,100
+2,454
| +9% | +$296K | 0.1% | 140 |
|
|
2021
Q3 | $3.6M | Sell |
28,646
-2,030
| -7% | -$261K | 0.07% | 183 |
|
|
2021
Q2 | $4.15M | Buy |
30,676
+3,066
| +11% | +$403K | 0.08% | 175 |
|
|
2021
Q1 | $3.75M | Sell |
27,610
-3,435
| -11% | -$514K | 0.09% | 157 |
|
|
2020
Q4 | $4.37M | Sell |
31,045
-2,195
| -7% | -$281K | 0.11% | 134 |
|
|
2020
Q3 | $3.7M | Sell |
33,240
-2,020
| -6% | -$226K | 0.1% | 138 |
|
|
2020
Q2 | $3.95M | Sell |
35,260
-9,135
| -21% | -$900K | 0.12% | 122 |
|
|
2020
Q1 | $3.44M | Buy |
44,395
+3,855
| +10% | +$341K | 0.12% | 125 |
|
|
2019
Q4 | $3.86M | Sell |
40,540
-20
| -0% | -$1.73K | 0.11% | 130 |
|
|
2019
Q3 | $3.09M | Buy |
40,560
+85
| +0.2% | +$7.06K | 0.1% | 152 |
|
|
2019
Q2 | $3.55M | Sell |
40,475
-385
| -0.9% | -$32.8K | 0.11% | 140 |
|
|
2019
Q1 | $3.7M | Buy |
+40,860
| New | +$3.48M | 0.12% | 132 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$260K | – | 165 |
|
|
2017
Q3 | $260K | Sell |
3,000
-700
| -19% | -$56.1K | 0.01% | 144 |
|
|
2017
Q2 | $286K | Sell |
3,700
-3,400
| -48% | -$241K | 0.02% | 139 |
|
|
2017
Q1 | $492K | Buy |
+7,100
| New | +$477K | 0.03% | 98 |
|
Other funds holding XBI
ACA